Akebia Therapeutics, Inc. Annual Operating Margin in % from 2016 to 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Akebia Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2016 to 2023.
  • Akebia Therapeutics, Inc. Operating Margin for the quarter ending September 30, 2024 was -20.5 %, a 24.3% increase year-over-year.
  • Akebia Therapeutics, Inc. annual Operating Margin for 2023 was -23.8 %, a 13.9% increase from 2022.
  • Akebia Therapeutics, Inc. annual Operating Margin for 2022 was -27.6 %, a 77.9% increase from 2021.
  • Akebia Therapeutics, Inc. annual Operating Margin for 2021 was -125 %, a 2.54% increase from 2020.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -23.8 +3.85 +13.9% Jan 1, 2023 Dec 31, 2023
2022 -27.6 +97.4 +77.9% Jan 1, 2022 Dec 31, 2022
2021 -125 +3.26 +2.54% Jan 1, 2021 Dec 31, 2021
2020 -128 -42.8 -50% Jan 1, 2020 Dec 31, 2020
2019 -85.5 +0.3 +0.35% Jan 1, 2019 Dec 31, 2019
2018 -85.8 -43.5 -103% Jan 1, 2018 Dec 31, 2018
2017 -42.3 +8.85K +99.5% Jan 1, 2017 Dec 31, 2017
2016 -8.89K Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.